Perspectives on Private Equity

Mark Zaander will speak on a panel that Tyler Margolis will moderate at the ACIC Spring Investment Forum on April 28, 2023.

On March 27, the US Securities and Exchange Commission (SEC) released a risk alert focusing on the SEC’s conclusions after its routine examination of newly registered investment advisors.

ArentFox Schiff advised Kindeva Drug Delivery in its combination with Meridian Medical Technologies.

On August 10, 2022, the US Securities and Exchange Commission (SEC) and the Commodity Futures Trading Commission (CFTC) issued a joint proposal to amend Form PF,[1] a reporting form for SEC-registered reporting private fund advisers to require enhanced periodic disclosures.

ArentFox Schiff is pleased to announce that the firm and two partners have been shortlisted for the annual LMG Life Sciences Americas Awards.

On June 14, 2022, the US Securities and Exchange Commission (SEC) released an order charging private equity adviser Energy Capital Partners Management, LP (ECP) with Investment Advisers Act violations in connection with a 2018 take-private transaction.

ArentFox Schiff advised Altaris Capital Partners on the approximately $241 million take-private acquisition of Intricon Corporation, an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging.

ArentFox Schiff is representing Clearwater Compliance LLC (Clearwater) in its definitive agreement for the take-private acquisition of CynergisTek, Inc., a leading cybersecurity, privacy, compliance, and IT audit firm.

Centre Partners, a private equity firm specializing in the healthcare and consumer industries, engaged ArentFox Schiff to represent physician-owners and management in the sale of Vision Innovation Partners.

Schiff Hardin today announced the expansion of its Corporate and Transactional Practice Group with the addition of counsel Andrew Banks in New York and associates Darcy Lee and Cody Boender in Chicago.

Schiff has advised BK Medical in entering into an agreement to be sold to GE Healthcare for $1.45 billion.

Schiff advised Altaris Capital Partners, LLC on its acquisition of Padagis LLC, formerly the generic prescription pharmaceuticals business of Perrigo Company plc, for $1.55 billion.

Altaris Capital Partners, LLC has announced that it has entered into an agreement to sell Paramit Corporation to The Tecan Group for $1 billion.

Schiff Hardin represented Altaris Capital Partners, LLC in the sale of Senior Helpers, an owner and franchisor of professional home care services designed to allow elderly individuals to stay in their homes as long as possible.

Schiff Hardin LLP represented Altaris Capital Partners, LLC, a private investment firm focused on the healthcare industry, in its agreement to acquire Perrigo Company plc’s prescription pharmaceuticals business (Rx) for $1.55 billion.

Schiff Hardin LLP represented Altaris Capital Partners, LLC, a private investment firm focused on the healthcare industry, in the majority recapitalization of Minnetronix Medical, Inc., a leading medical technology and operations partner to global medical device companies.

Schiff Hardin LLP represented Altaris Capital Partners LLC, a private investment firm focused on the healthcare industry, in its $650 million acquisition of substantially all of Kindeva Drug Delivery from 3M Company.

Schiff Hardin LLP represented Newell Brands, a leading global consumer goods company, in the sale of its Rexair business to investment funds affiliated with Rhône Capital, a global private equity firm.

Schiff Hardin LLP served as legal counsel to Altaris Capital Partners in connection with an Altaris affiliate’s acquisition of Analogic Corporation for approximately $1.1 billion.

Schiff Hardin LLP today announced that Olga Bogush has joined the firm’s Tax Practice as a partner in the New York office.

The Tax Cuts and Jobs Act (the “Act”) will dramatically change the tax treatment of income from many partnerships, limited liability companies, and S corporations.